Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Minerva Neurosciences (NERV) Total Current Liabilities (2016 - 2026)

Minerva Neurosciences filings provide 3 years of Total Current Liabilities readings, the most recent being $2.8 million for Q4 2021.

  • On a quarterly basis, Total Current Liabilities fell 10.8% to $2.8 million in Q4 2021 year-over-year; TTM through Dec 2021 was $2.8 million, a 10.8% decrease, with the full-year FY2021 number at $2.8 million, down 10.8% from a year prior.
  • Total Current Liabilities hit $2.8 million in Q4 2021 for Minerva Neurosciences, down from $3.1 million in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $7.4 million in Q2 2020 to a low of $2.8 million in Q4 2021.
  • Median Total Current Liabilities over the past 3 years was $4.4 million (2021), compared with a mean of $4.8 million.
  • The widest YoY moves for Total Current Liabilities: up 10.8% in 2021, down 52.82% in 2021.
  • Minerva Neurosciences' Total Current Liabilities stood at $6.6 million in 2019, then crashed by 52.33% to $3.2 million in 2020, then fell by 10.8% to $2.8 million in 2021.
  • The last three reported values for Total Current Liabilities were $2.8 million (Q4 2021), $3.1 million (Q3 2021), and $4.4 million (Q2 2021) per Business Quant data.